A patch injection device comprising a housing, an adhesive substrate having a first surface with a first surface area for skin attachment and a second surface which is opposite the first surface attaching partly to the housing and a removable release liner. The surface area of the second surface attaching to the housing is smaller than the first surface area and the excess area defines a skirt of the substrate at least partially surrounding the housing. The first surface of the substrate attaches to the removable release liner which fully covers the first surface area of the substrate. Furthermore a pull tab is provided being part of the release liner and located in a cut-out of the skirt of the substrate such that a peel force is transmittable from the release liner to the housing at the location where the cut-out reaches the housing.

The invention relates to a mobile selection system for selecting medical accessories comprising a control system, a user interface and a treatment cart. The treatment cart comprises a plurality of storage devices each having at least two storage areas for a respective accessory type. The control system thereby implements a selection method having the following method steps. The treatment identifier of the treatment to be performed is determined in one method step via the user interface. In a further method step, a plurality of accessory set parameters which characterize a medical accessory set are determined on the basis of an accessory database and on the basis of the treatment identifier of the treatment to be performed. The treatment cart comprises a release mechanism, wherein the control system is designed to control the release mechanism so as to release those medical accessories for which at least one of the storage devices comprises storage area for their accessory types and which are characterized by the accessory set parameters on which the control is based.

Kits enabling an end user to efficiently compound inhalable formulations containing medicinal compounds, for use in in aerosol device (e-cigarette; personal vaporizer). Kits include a reusable storage device, a filling station, at least one predetermined amount aerosol precursor in a container and at least one empty cartomizer (cartridge) for use in an aerosol delivery device. Optionally, kits may also include a predetermined amount of extract containing a known amount of medicinal compound, enabling the production of an amount an inhalable formulation. Optionally, kits may contain amounts of inputs that enable the refilling/reuse of cartridges.

Disclosed are an apparatus, system, a kit and a method for delivering supplemental oxygen together with an aromatherapy active. The system comprises one or more oxygen containers for delivering of supplemental oxygen comprising between 35 and 40 percent oxygen—to a user. The system comprise one or more selectable aromatherapy pods, which may be incorporated into the supplemental oxygen delivery system to increase user satisfaction and promote the frequent use of the supplemental oxygen therapy to improve athletic performance.

The present invention relates to a handheld vibrating mesh nebuliser for delivery of a medicament to the respiratory system in therapy. The present invention also relates to a supply container for loading the nebuliser with liquid medicament. The present invention also relates to a kit for delivery of a medicament to a respiratory system and a method of loading a vibrating mesh nebuliser with liquid medicament from a supply container. The present invention also relates to compositions for use in a method of treatment of a respiratory disease in a patient by therapy.

Systems and methods for pumping milk from a breast, wherein the milk is expressed from the breast under suction and milk is expulsed from the pumping mechanism to a collection container assembly.

A patient interface including a seal-forming structure with a textile membrane that has at least one hole such that the flow of air at a therapeutic pressure is delivered to at least an entrance to the patients nares and/or an entrance to the patients mouth. The seal-forming structure is constructed and arranged to maintain the therapeutic pressure in a cavity of a plenum chamber throughout the patients respiratory cycle, in use. The textile membrane includes a first portion that is held in a relaxed state and a second portion that is held in a taut state. The taut state of the second portion is configured to allow the seal-forming structure to include a three-dimensional shape that has multiple curvatures.

Provided herein are dry powder formulations comprising epinephrine alone or in combination with at least one enabling agent suitable for nasal application. Also provided are unit dose forms and devices comprising such formulations and methods of using such formulations for the treatment of various conditions including anaphylaxis, anaphylactoid reaction, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening conditions.

A device (100) for facilitating the positioning of a catheter for the administration of a liquid medicament to a spontaneously breathing patient. The method and system according to preferred embodiments of the present invention allows optimizing the dispensing said medicaments. In particular the system according to a preferred embodiment of the present invention allows the administration of an exogenous pulmonary surfactant to preterm patients.

Provided herein are drug products adapted for nasal delivery comprising a device and a pharmaceutical composition comprising an opioid receptor antagonist or unit doses thereof, pharmaceutical compositions comprising an opioid receptor antagonist, and methods of use and preparation thereof.